Suramin treatment reduces chikungunya pathogenesis in mice.

[1]  H. Rothan,et al.  Mefenamic acid in combination with ribavirin shows significant effects in reducing chikungunya virus infection in vitro and in vivo. , 2016, Antiviral research.

[2]  S. Chattopadhyay,et al.  Inhibition of Chikungunya Virus Replication by 1-[(2-Methylbenzimidazol-1-yl) Methyl]-2-Oxo-Indolin-3-ylidene] Amino] Thiourea(MBZM-N-IBT) , 2016, Scientific Reports.

[3]  M. Purswani,et al.  Post-chikungunya rheumatic disorders in travelers after return from the Caribbean. , 2016, Travel medicine and infectious disease.

[4]  M. Diamond,et al.  Neutralizing Monoclonal Antibodies Block Chikungunya Virus Entry and Release by Targeting an Epitope Critical to Viral Pathogenesis. , 2015, Cell reports.

[5]  D. Fremont,et al.  Broadly Neutralizing Alphavirus Antibodies Bind an Epitope on E2 and Inhibit Entry and Egress , 2015, Cell.

[6]  M. V. van Hemert,et al.  Suramin inhibits chikungunya virus replication through multiple mechanisms. , 2015, Antiviral research.

[7]  J. Chu,et al.  Antiviral Phosphorodiamidate Morpholino Oligomers are Protective against Chikungunya Virus Infection on Cell-based and Murine Models , 2015, Scientific Reports.

[8]  Tzong-Yuan Wu,et al.  Suramin Inhibits Chikungunya Virus Entry and Transmission , 2015, PloS one.

[9]  A. Rodríguez-Morales,et al.  How many patients with post-chikungunya chronic inflammatory rheumatism can we expect in the new endemic areas of Latin America? , 2015, Rheumatology International.

[10]  R. Muñoz-Louis,et al.  Chikungunya infection in the general population and in patients with rheumatoid arthritis on biological therapy , 2015, Clinical Rheumatology.

[11]  Lara J. Herrero,et al.  Pentosan Polysulfate: a Novel Glycosaminoglycan-Like Molecule for Effective Treatment of Alphavirus-Induced Cartilage Destruction and Inflammatory Disease , 2015, Journal of Virology.

[12]  M. Diamond,et al.  Brief Report: Chikungunya Viral Arthritis in the United States: A Mimic of Seronegative Rheumatoid Arthritis , 2015, Arthritis & rheumatology.

[13]  E. Javelle,et al.  Specific Management of Post-Chikungunya Rheumatic Disorders: A Retrospective Study of 159 Cases in Reunion Island from 2006-2012 , 2015, PLoS neglected tropical diseases.

[14]  Penny A. Rudd,et al.  Multiple Immune Factors Are Involved in Controlling Acute and Chronic Chikungunya Virus Infection , 2014, PLoS neglected tropical diseases.

[15]  Lara J. Herrero,et al.  Bindarit, an Inhibitor of Monocyte Chemotactic Protein Synthesis, Protects against Bone Loss Induced by Chikungunya Virus Infection , 2014, Journal of Virology.

[16]  X. de Lamballerie,et al.  Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral. , 2014, The Journal of antimicrobial chemotherapy.

[17]  M. Heise,et al.  Residue 82 of the Chikungunya Virus E2 Attachment Protein Modulates Viral Dissemination and Arthritis in Mice , 2014, Journal of Virology.

[18]  P. Fiorina,et al.  Inhibition of the purinergic pathway prolongs mouse lung allograft survival. , 2014, American journal of respiratory cell and molecular biology.

[19]  R. Román-Ramos,et al.  Hypoglycemic and Hypotensive Activity of a Root Extract of Smilax aristolochiifolia, Standardized on N-trans-Feruloyl-Tyramine , 2014, Molecules.

[20]  A. Sugunan,et al.  Chronic inflammatory arthritis with persisting bony erosions in patients following chikungunya infection , 2014, The Indian journal of medical research.

[21]  H. Nakaya,et al.  CCR2 Deficiency Promotes Exacerbated Chronic Erosive Neutrophil-Dominated Chikungunya Virus Arthritis , 2014, Journal of Virology.

[22]  C. Sorzano,et al.  A Novel Poxvirus-Based Vaccine, MVA-CHIKV, Is Highly Immunogenic and Protects Mice against Chikungunya Infection , 2014, Journal of Virology.

[23]  P. Buchy,et al.  The approved pediatric drug suramin identified as a clinical candidate for the treatment of EV71 infection—suramin inhibits EV71 infection in vitro and in vivo , 2014, Emerging Microbes and Infections.

[24]  P. Roques,et al.  Novel Attenuated Chikungunya Vaccine Candidates Elicit Protective Immunity in C57BL/6 mice , 2013, Journal of Virology.

[25]  J. Cullen,et al.  Chikungunya Virus Host Range E2 Transmembrane Deletion Mutants Induce Protective Immunity against Challenge in C57BL/6J Mice , 2013, Journal of Virology.

[26]  D. Fremont,et al.  University of Groningen Development of a Highly Protective Combination Monoclonal Antibody Therapy against Chikungunya Virus Pal, , 2013 .

[27]  M. Albert,et al.  Chikungunya Virus-associated Long-term Arthralgia: A 36-month Prospective Longitudinal Study , 2013, PLoS neglected tropical diseases.

[28]  Sandip Das,et al.  Suramin ameliorates collagen induced arthritis. , 2012, International immunopharmacology.

[29]  M. Rolph,et al.  Protection from arthritis and myositis in a mouse model of acute chikungunya virus disease by bindarit, an inhibitor of monocyte chemotactic protein-1 synthesis. , 2011, The Journal of infectious diseases.

[30]  Yen-Chung Chang,et al.  Cell-based analysis of Chikungunya virus membrane fusion using baculovirus-expression vectors. , 2011, Journal of virological methods.

[31]  A. Suhrbier,et al.  A complex adenovirus vaccine against chikungunya virus provides complete protection against viraemia and arthritis. , 2011, Vaccine.

[32]  S. Elmore,et al.  A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. , 2011, The American journal of pathology.

[33]  A. Hamasha,et al.  Analysis of Immunohistochemical Expression of K19 in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma Using Color Deconvolution-Image Analysis Method , 2010, Head and neck pathology.

[34]  P. Gasque,et al.  Emergence and clinical insights into the pathology of Chikungunya virus infection , 2010, Expert review of anti-infective therapy.

[35]  Thibaut Larcher,et al.  Chikungunya Virus Arthritis in Adult Wild-Type Mice , 2010, Journal of Virology.

[36]  A. Sugunan,et al.  Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging. , 2010, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[37]  B. Combe,et al.  A report of 21 cases of rheumatoid arthritis following Chikungunya fever. A mean follow-up of two years. , 2009, Joint, bone, spine : revue du rhumatisme.

[38]  P. Buchwald,et al.  Suramin inhibits the CD40-CD154 costimulatory interaction: a possible mechanism for immunosuppressive effects. , 2009, Biochemical pharmacology.

[39]  R. McGeary,et al.  Suramin: clinical uses and structure-activity relationships. , 2008, Mini reviews in medicinal chemistry.

[40]  A. Chopra,et al.  Chikungunya virus aches and pains: an emerging challenge. , 2008, Arthritis and rheumatism.

[41]  A. Toivanen.  Alphaviruses: an emerging cause of arthritis? , 2008, Current opinion in rheumatology.

[42]  Fabrice Chrétien,et al.  A Mouse Model for Chikungunya: Young Age and Inefficient Type-I Interferon Signaling Are Risk Factors for Severe Disease , 2008, PLoS pathogens.

[43]  S. Higgs,et al.  A Single Mutation in Chikungunya Virus Affects Vector Specificity and Epidemic Potential , 2007, PLoS pathogens.

[44]  Didier Fontenille,et al.  Two Chikungunya Isolates from the Outbreak of La Reunion (Indian Ocean) Exhibit Different Patterns of Infection in the Mosquito, Aedes albopictus , 2007, PloS one.

[45]  P. Desprès,et al.  Human Muscle Satellite Cells as Targets of Chikungunya Virus Infection , 2007, PloS one.

[46]  Frank Kunst,et al.  Genome Microevolution of Chikungunya Viruses Causing the Indian Ocean Outbreak , 2006, PLoS medicine.

[47]  A. Suhrbier,et al.  Clinical and pathologic aspects of arthritis due to Ross River virus and other alphaviruses , 2004, Current opinion in rheumatology.

[48]  T. Martin,et al.  Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. , 2002, The American journal of pathology.

[49]  D. Purdie,et al.  Natural history of Ross River virus‐induced epidemic polyarthritis , 2002, The Medical journal of Australia.

[50]  Massimo Mabilia,et al.  Inhibition of tumor necrosis factor-α (TNF-α)/ TNF-α receptor binding by structural analogues of suramin , 1999 .

[51]  F. Mancini,et al.  Inhibition of tumor necrosis factor-alpha (TNF-alpha)/TNF-alpha receptor binding by structural analogues of suramin. , 1999, Biochemical pharmacology.

[52]  T. Yoneda,et al.  Suramin suppresses hypercalcemia and osteoclastic bone resorption in nude mice bearing a human squamous cancer. , 1995, Cancer research.

[53]  O. Prozesky,et al.  Chikungunya virus infection. A retrospective study of 107 cases. , 1983, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.